Atossa Therapeutics leading clinical trial that may improve pulmonary function in COVID-19 patients

Name: Atossa Therapeutics leading clinical trial that may improve pulmonary function in COVID-19 patients
Uploaded: 2020-04-06T14:08:25Z
Duration: 4 min 27 s
Description: Dr. Steven Quay, physician scientist and Atossa Therapeutics CEO, joins 'America's Newsroom' to explain.